Edition:
United States

Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.89USD
25 Jul 2016
Change (% chg)

$-0.08 (-4.06%)
Prev Close
$1.97
Open
$1.93
Day's High
$1.96
Day's Low
$1.87
Volume
16,869
Avg. Vol
36,717
52-wk High
$4.15
52-wk Low
$1.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.23 December 25 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2 0.25 0.30 0.20 --
Quarter Ending Dec-16 2 0.25 0.30 0.20 --
Year Ending Dec-16 2 0.90 1.00 0.80 15.70
Year Ending Dec-17 2 12.00 22.60 1.40 27.60
Earnings (per share)
Quarter Ending Sep-16 2 -0.23 -0.18 -0.28 --
Quarter Ending Dec-16 2 -0.24 -0.20 -0.28 --
Year Ending Dec-16 2 -1.00 -0.90 -1.11 -0.05
Year Ending Dec-17 2 -0.06 0.46 -0.59 1.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 0.15 0.22 0.07 49.33
Quarter Ending Dec-15 2.70 2.68 0.02 0.78
Quarter Ending Sep-15 3.10 0.21 2.89 93.23
Quarter Ending Jun-15 2.90 0.34 2.56 88.24
Quarter Ending Mar-15 7.60 5.36 2.24 29.48
Earnings (per share)
Quarter Ending Mar-16 -0.26 -0.28 0.02 -7.69
Quarter Ending Dec-15 -0.03 -0.08 0.05 -166.67
Quarter Ending Sep-15 0.00 -0.23 0.23 0.00
Quarter Ending Jun-15 -0.10 -1.25 1.15 -1,150.00
Quarter Ending Mar-15 0.68 0.75 0.07 11.11

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.25 0.25 0.25 0.25 --
Quarter Ending Dec-16 0.25 0.25 0.25 0.25 --
Year Ending Dec-16 0.90 0.90 0.90 0.90 15.70
Year Ending Dec-17 12.00 12.00 12.00 12.00 27.60
Earnings (per share)
Quarter Ending Sep-16 -0.23 -0.23 -0.23 -0.23 --
Quarter Ending Dec-16 -0.24 -0.24 -0.24 -0.24 --
Year Ending Dec-16 -1.00 -1.00 -1.00 -1.00 -0.05
Year Ending Dec-17 -0.06 -0.06 -0.06 -0.06 1.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.